Living Well Program for Anxiety in Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the Living Well Program, a digital therapy app with telecoaching, can reduce healthcare costs and ease anxiety in breast cancer patients. Participants will use the app and join telecoaching sessions to address anxiety over a 6-month period, followed by a follow-up phase. It suits individuals with stage II to IV breast cancer who experience moderate to severe anxiety and are beginning cancer treatment. As an unphased trial, this study provides a unique opportunity to explore innovative digital therapy solutions for managing anxiety.
What prior data suggests that the Living Well Program is safe for breast cancer patients with anxiety?
A previous study of the Living Well Program showed very few potential risks. The main concern was that some participants might feel upset when answering questions about their health. However, the study reported no serious side effects, suggesting that the program is generally safe for users. The program employs online support and phone coaching to help manage anxiety in breast cancer patients, aiming to improve mental health without significant risks.12345
Why are researchers excited about this trial?
Researchers are excited about the Living Well Program because it offers a fresh approach to managing anxiety in breast cancer patients. Unlike traditional treatments such as medication and therapy sessions, this program utilizes a digital app combined with telecoaching sessions, making it more accessible and flexible for patients. This method empowers individuals to engage with their mental health management on their own schedule, potentially improving adherence and outcomes. The innovative use of technology in this program could redefine how supportive care is delivered to breast cancer patients, providing personalized support that fits into their daily lives.
What evidence suggests that the Living Well Program is effective for anxiety in breast cancer patients?
Research shows that the Living Well Program, which participants in this trial will engage with, can significantly reduce anxiety in breast cancer patients. Previous studies have shown promising results, with improvements in anxiety, fatigue, and sleep issues. For example, using apps like the Living Well Program led to noticeable decreases in anxiety symptoms for breast cancer patients. Additionally, participants reported high satisfaction with the program, finding it both helpful and enjoyable. These results suggest that using the Living Well app with support from a coach could effectively manage anxiety in breast cancer patients.12678
Who Is on the Research Team?
Scott Irwin, MD
Principal Investigator
Cedars-Sinai Medical Center
Are You a Good Fit for This Trial?
This trial is for breast cancer patients with moderate-to-severe anxiety. Participants must be diagnosed with stage II to IV breast cancer and experiencing mental health challenges like depression or anxiety disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Active Intervention
Participants use the Living Well app and complete 21 mental health modules and 5 telecoaching sessions over 3 months
Extended Monitoring
Participants complete any outstanding modules and telecoaching sessions while being monitored
Follow-up
Participants are monitored for safety and effectiveness after treatment, with access to the app for continued use
What Are the Treatments Tested in This Trial?
Interventions
- Living Well Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Scott A. Irwin, MD, PhD
Lead Sponsor
Cedars-Sinai Medical Center
Collaborator
Prosoma
Collaborator